Valor20212022202320242025TTMFluxo de caixa de investimento274.4 M-77.5 M31.9 M-11.9 M-27.4 M-25.6 MFluxo de caixa de financiamento-150.6 M-8 M152.9 M-7.4 M64.2 M47.6 MFluxo de caixa livre200 K-151.6 M-110.9 M-8.7 M-10 M-7.5 M
Myriad Genetics, Inc. - Common Stock
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.